Humanigen Operating Cycle 2011-2026 | HGEN

Quarterly Operating Cycle Humanigen

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	20.6	4.4	-	-	-	221	470	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
470	4.4	179

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Alnylam Pharmaceuticals ALNY	102	$ 330.79	3.74 %	$ 43.3 B	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Aquestive Therapeutics AQST	223	$ 4.11	-0.48 %	$ 439 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.24	2.55 %	$ 226 M	Israel
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
Celldex Therapeutics CLDX	321	$ 31.36	0.97 %	$ 2.08 B	USA
Arcutis Biotherapeutics ARQT	291	$ 23.46	-0.72 %	$ 2.98 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	127	-	-	$ 546 M	USA
Brickell Biotech BBI	254	-	-5.38 %	$ 6.06 M	USA
Ardelyx ARDX	1.05 K	$ 6.01	1.18 %	$ 1.45 B	USA
CASI Pharmaceuticals CASI	135	-	-	$ 35.4 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA